IMMUNOVANT, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- IMMUNOVANT, INC. stock issued during period, value, stock options exercised for the quarter ending 2020-12-31 was $725.00K.
- IMMUNOVANT, INC. stock issued during period, value, stock options exercised for the quarter ending 2020-09-30 was $119.00K.
- IMMUNOVANT, INC. stock issued during period, value, stock options exercised for the quarter ending 2020-06-30 was $63.00K.
- IMMUNOVANT, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $907.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2021-03-31 | $907.00K 10-K · filed 2022-06-08 | |
| 2020-12-31 | $725.00K 10-Q · filed 2022-02-04 | |
| 2020-09-30 | $119.00K 10-Q · filed 2022-02-04 | |
| 2020-06-30 | $63.00K 10-Q · filed 2022-02-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |